Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of nearly 7,000 products to over 1,000 customers annually. Catalent’s expert workforce exceeds 19,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit www.catalent.com. More products. Better treatments. Reliably supplied.™

Introducing Catalent Xpress Pharmaceutics™ – Facilitate Adaptive Trials and Accelerate Phase 1

View video on external website

Boosting Bioavailability: How Companies are Using Advanced Technologies to Formulate Complex Molecules

Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening